Purpose: To develop a Physicians' Guide to assist clinicians in the concomitant use of
glaucoma and systemic medications. Methods: The records of 100 consecutive patients with …

The use of any active pharmacological agent invariably is associated with unwanted
occurrences to which we give the name side effects or adverse effects. In some cases, these …

For some time the medical treatment of glaucoma has consisted of topical β-blockers,
adrenergic agents, miotics and oral carbonic anhydrase inhibitors (CAIs). However, the …

A controlled double-blind crossover study of ocular complications associated with nebulized
ipratropium bromide and salbutamol therapy for respiratory distress was undertaken in 46 …

Br J Ophthalmol: first published as 10.1136/bjo. 86.6. 691 on 1 June 2002. Downloaded
from more potent than dipivefrin and less likely to provoke surface discomfort or allergic …

We compared the ocular-hypotensive efficacy and systemic and ocular safety of an
ophthalmic solution of levobunolol (0.5% and 1%) twice daily, with timolol (0.5%) twice daily …

Background: There is evidence that the ocular hypotensive effect of topical betablockers
persists for at least 24 hours once beta-blockade has been achieved. In previous studies …

Even with the availability of these newer agents, we believe that [beta] blockers, which have
been a mainstay of medical glaucoma management for over 20 years for many very good …

Introduction Few studies have examined outcomes and potential complications among
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …

Purpose To compare the effect of timolol with or without preservatives on the conjunctival
epithelium of glaucoma patients. Methods A retrospective study using impression cytology …